High-impact international
corporate development

It takes more than just business development to develop a business 

Transforming companies and crossing the chasm to evolve private wealth portfolios with operating business assets 



Increase your capacity for growth and change management by closing your resourcing gaps - be among the 30% that successfully transform their business (70% have failed) 

Transitioning middle market enterprise valuations & liquidity 

for high net worth shareholders and private wealth portfolios

cross-border Accelerator

DeltaStreet and IISc's FSID are accelerating innovative manufacturing product/process IP projects with international corporate development (ICD) value addition, capital efficiencies and global joint venture (JV) initiatives for the underlying operating businesses

To be globally competitive, the cross-border structure of an operating business needs to evolve alongside its international growth strategy from the very start—not in separate stages since these are not independent of each other. This approach ensures the business keeps pace with fast-changing niche supply chains and shifting macroeconomic trends in each target market. For example, many firms are expanding in different parts of the world through regional joint venturing, developing indigenized product IP for local markets, or even engaging in M&A transactions to address elevated tariff and trade impediments.


This principle is central to the International Corporate Development or ICD value proposition of DeltaStreet - reach out for an invigorating discussion on how your company may benefit from such ICD to enhance its business valuation, capital structure and liquidity.

growth

Scaling up mid-sized firms  towards elevated market valuations and liquidity 

milestones

Shareholder wealth evolution from a single growth business to building a diversified private portfolio of alternative assets  

tools

IP / Joint Venture projects, M&A, global distribution networks, grant/incentive schemes & sources of efficient risk capital  

strategies

Augment organic growth, align industry with science/academia & government, expand supply chains, (re-)capitalize balance sheet structure

paths

Continuous innovation tactics, developing new products  & refining applied technologies through R&D lab infrastructure, debt/equity funding partners

benefits

Increased domestic/export market share & brand visibility,  improved operating company valuations & liquidity, better portfolio risk/returns

get in touch

Ronnie (Rajnish) Dayal

 President, Delta Street Holdings Inc.

ronnie@deltastreet.com

+1 (416) 844 5165